Showing results (531-540 of 1,171) with videos related to
Sort By:
Pageof 118
Cancer Chemotherapy and Pharmacology|January 1, 1992
Pharmacodynamics of three daily infusions of etoposide in patients with extensive-stage small-cell lung cancerA A Miller, E A Tolley, H B Niell, et al.Digestive Diseases and Sciences|July 6, 2000
Abdominal pain, bloating, and diarrhea in the United States: prevalence and impactR S Sandler, W F Stewart, J N Liberman, et al.Cancer Chemotherapy and Pharmacology|February 28, 2001
Effect of hemodialysis on topotecan disposition in a patient with severe renal dysfunctionJ D Herrington, J A Figueroa, M N Kirstein, et al.Nucleic Acids Research|April 13, 1999
The chicken HPRT gene: a counter selectable marker for the DT40 cell lineT Fukagawa, N Hayward, J Yang, et al.The Journal of Clinical Endocrinology and Metabolism|January 1, 1996
Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH(1-34) in humansM Everhart-Caye, S E Inzucchi, J Guinness-Henry, et al.European Journal of Cancer & Clinical Oncology|May 1, 1984
Adriamycin and mitomycin C as initial chemotherapy for advanced breast cancerS A Amiel, J F Stewart, H M Earl, et al.Journal of Clinical Pharmacology|September 19, 2017
Bridging Adult Experience to Pediatrics in Oncology Drug DevelopmentRuby Leong, Hong Zhao, Gregory Reaman, et al.Arthritis and Rheumatism|December 1, 1991
Aspirin alters methotrexate disposition in rheumatoid arthritis patientsC F Stewart, R A Fleming, B F Germain, et al.The Journal of Trauma|August 12, 2010
Intermediate-term follow-up of patients treated with percutaneous embolization for grade 5 blunt renal traumaAdam F Stewart, M Eric Brewer, Brian J Daley, et al.Anticancer Research|September 12, 2013
Combination metronomic oral topotecan and pazopanib: a pharmacokinetic study in patients with gynecological cancerDavid C Turner, Todd D Tillmanns, K Elaine Harstead, et al.Pageof 118